1 |
Máčalík R, Petráš M, Čelko AM, Chmátal P, Tlapák J, Dlouhý P, Malinová J, Lesná IK. BMI-Associated Anti-Apolipoprotein A-1 Positivity in Healthy Adults after mRNA-Vaccination against COVID-19. Vaccines 2023;11:670. [DOI: 10.3390/vaccines11030670] [Reference Citation Analysis]
|
2 |
Faguer S, Del Bello A, Danet C, Renaudineau Y, Izopet J, Kamar N. Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study. Front Pharmacol 2022;13:936659. [DOI: 10.3389/fphar.2022.936659] [Reference Citation Analysis]
|
3 |
Vuilleumier N, Pagano S, Ludewig B, Schmiedeberg K, Haller C, von Kempis J, Rubbert-Roth A. Anti-SARS-CoV-2 mRNA vaccines as inducers of humoral response against apolipoprotein A-1? Eur J Clin Invest 2022;52:e13713. [PMID: 34841527 DOI: 10.1111/eci.13713] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
4 |
Twickler DTM. New insights into Covid-19 disease. Apo-A1 antibodies are generated after mRNA Covid-19 vaccination and after Covid-19 infection. Eur J Clin Invest 2022;52:e13729. [PMID: 34921724 DOI: 10.1111/eci.13729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Pagano S, Yerly S, Meyer B, Juillard C, Suh N, Le Terrier C, Daguer JP, Farrera-Soler L, Barluenga S, Piumatti G, Hartley O, Lemaitre B, Eberhardt CS, Siegrist CA, Eckerle I, Stringhini S, Guessous I, Kaiser L, Pugin J, Winssinger N, Vuilleumier N. SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1. Eur J Clin Invest 2021;51:e13661. [PMID: 34324704 DOI: 10.1111/eci.13661] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|